In these inflammatory cells, we verified a significant up-regulation of ANXA1 and FPR2/ALX expression in the peritumoral and tumor samples compared with the corresponding control tissues (Fig. 2, G–L). This evidence concerns the gene ANXA1 and neoplasm.